New Data Blocking and Interoperability Rules: Implications for Healthcare Providers, Payers, Vendors
Navigating the Shift in Healthcare Information Technology and Complying With the Rules
Recording of a 90-minute CLE webinar with Q&A
This CLE course will guide healthcare counsel on the final data blocking and interoperability rules. The panel will discuss the implications for healthcare providers, payers, and vendors. The panel will also offer best practices for addressing the changes and steps for complying with the new rules.
- Data blocking rules
- Interoperability rules
- Implications of the new rules
- Complying with the new rules
The panel will review these and other key issues:
- How do the new rules change the landscape for healthcare providers? Payers? Vendors?
- What are the exceptions under ONC's interoperability and information blocking rule?
- What must healthcare providers do now to ensure compliance with the new rules?
Nan Bonifant Halstead
Ms. Halstead is a member of the firm’s Life Sciences Health Industry Group, practicing in the area of healthcare... | Read More
Ms. Halstead is a member of the firm’s Life Sciences Health Industry Group, practicing in the area of healthcare regulatory law. Her practice focuses on the intersection of healthcare and technology, relying on her significant expertise in Medicare and Medicaid reimbursement, and HIPAA, health information privacy, Anti-Kickback Statute, beneficiary inducement, Stark, and 60 Day Overpayment Rule compliance to inform digital health strategies and arrangements. Ms. Halstead has extensive experience counselling healthcare providers, pharmaceutical and medical device manufacturers, and technology companies on collaboration agreements, value-based arrangements, strategic data partnerships, mobile health solutions and applications, connected devices, and breach incident response.Close
Ryan S. Johnson
Fredrikson & Byron
Mr. Johnson represents clients in a variety of transactions. He structures and negotiates acquisitions,... | Read More
Mr. Johnson represents clients in a variety of transactions. He structures and negotiates acquisitions, financings, equity offerings, joint ventures, strategic alliances, technology development and IP licensing arrangements. He also advises clients on a wide variety of regulatory and compliance matters, including FDA rules, state and federal privacy and security laws, fraud and abuse prohibitions.Close